XML 38 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Cash Equivalents, Marketable Securities and Fair Value Measurements (Tables)
3 Months Ended
Jun. 30, 2020
Fair Value Disclosures [Abstract]  
Cash Equivalents and Marketable Securities

The Company’s cash equivalents and marketable securities at June 30, 2020 and March 31, 2020 are invested in the following:

 

 

 

 

Amortized

 

 

Gross

Unrealized

 

 

Gross

Unrealized

 

 

Fair Market

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

June 30, 2020:

 

(in $000's)

 

Money market funds

 

$

130,012

 

 

$

 

 

$

 

 

$

130,012

 

Repurchase agreements

 

 

20,000

 

 

 

 

 

 

 

 

 

20,000

 

Total cash equivalents

 

 

150,012

 

 

 

 

 

 

 

 

 

150,012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short-term U.S. Treasury mutual fund securities

 

 

42,180

 

 

 

227

 

 

 

 

 

 

42,407

 

Short-term government-backed securities

 

 

39,921

 

 

 

210

 

 

 

 

 

 

40,131

 

Short-term corporate debt securities

 

 

109,426

 

 

 

588

 

 

 

 

 

 

110,014

 

Short-term commercial paper

 

 

19,898

 

 

 

86

 

 

 

 

 

 

19,984

 

Total short-term marketable securities

 

 

211,425

 

 

 

1,111

 

 

 

 

 

 

212,536

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term government-backed securities

 

 

75,483

 

 

 

66

 

 

 

(5

)

 

 

75,544

 

Long-term corporate debt securities

 

 

91,868

 

 

 

2,256

 

 

 

 

 

 

94,124

 

Total long-term marketable securities

 

 

167,351

 

 

 

2,322

 

 

 

(5

)

 

 

169,668

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

528,788

 

 

$

3,433

 

 

$

(5

)

 

$

532,216

 

 

 

 

Amortized

 

 

Gross

Unrealized

 

 

Gross

Unrealized

 

 

Fair Market

 

 

 

Cost

 

 

Gains

 

 

Losses

 

 

Value

 

March 31, 2020:

 

(in $000's)

 

Money market funds

 

$

115,019

 

 

$

 

 

$

 

 

$

115,019

 

Repurchase agreements

 

 

20,000

 

 

 

 

 

 

 

 

 

20,000

 

Total cash equivalents

 

 

135,019

 

 

 

 

 

 

 

 

 

135,019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Short-term U.S. Treasury securities

 

 

42,236

 

 

 

412

 

 

 

 

 

 

42,648

 

Short-term government-backed securities

 

 

67,594

 

 

 

401

 

 

 

 

 

 

67,995

 

Short-term corporate debt securities

 

 

107,290

 

 

 

94

 

 

 

(83

)

 

 

107,301

 

Short-term commercial paper

 

 

32,757

 

 

 

74

 

 

 

 

 

 

32,831

 

Total short-term marketable securities

 

 

249,877

 

 

 

981

 

 

 

(83

)

 

 

250,775

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Long-term government-backed securities

 

 

90,911

 

 

 

153

 

 

 

 

 

 

91,064

 

Long-term corporate debt securities

 

 

116,110

 

 

 

851

 

 

 

(230

)

 

 

116,731

 

Total long-term marketable securities

 

 

207,021

 

 

 

1,004

 

 

 

(230

)

 

 

207,795

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

591,917

 

 

$

1,985

 

 

$

(313

)

 

$

593,589

 

Schedule of Cross-Currency Rate Swap Derivatives Agreement

The following table summarizes the terms of the cross-currency swap agreement as of June 30, 2020 (dollar amounts in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

Effective Date

 

Maturity

 

Fixed Rate

 

 

Aggregate Notional Amount

(in $000's)

 

Pay EUR

October 15,

 

October 15,

 

2.75%

 

 

 

EUR 85,000

 

Receive U.S.$

2019

 

2024

 

4.64%

 

 

 

USD 93,457

 

Schedule of Fair Value of Company's Derivative Instrument

The following table presents the fair value of the Company’s derivative instrument as of June 30, 2020:

 

 

 

 

 

 

 

 

Derivatives designated as hedging instruments under ASC 815

 

Balance Sheet classification

 

Fair Value

 

Cross-currency swap

 

Other assets (long-term liabilities)

 

$

1,504

 

Components of Contingent Consideration Liabilities

The components of contingent consideration liabilities are as follows:

 

 

 

 

 

 

June 30, 2020

 

 

March 31, 2020

 

 

 

(in $000's)

 

ECP

 

$

9,801

 

 

$

9,000

 

Breethe, Inc.

 

 

13,900

 

 

 

 

 

 

$

23,701

 

 

$

9,000

 

Financial Instruments Measured at Fair Value

The following tables present the Company’s fair value hierarchy for its financial instruments measured at fair value as of June 30, 2020 and March 31, 2020:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

June 30, 2020

 

(in $000's)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

130,012

 

 

$

 

 

$

 

 

$

130,012

 

Repurchase agreements

 

 

 

 

 

20,000

 

 

 

 

 

 

20,000

 

Short-term U.S. Treasury mutual fund securities

 

 

 

 

 

42,407

 

 

 

 

 

 

42,407

 

Short-term government-backed securities

 

 

 

 

 

40,131

 

 

 

 

 

 

40,131

 

Short-term corporate debt securities

 

 

 

 

 

110,014

 

 

 

 

 

 

110,014

 

Short-term commercial paper

 

 

 

 

 

19,984

 

 

 

 

 

 

19,984

 

Long-term government-backed securities

 

 

 

 

 

75,544

 

 

 

 

 

 

75,544

 

Long-term corporate debt securities

 

 

 

 

 

94,124

 

 

 

 

 

 

94,124

 

Cross-currency swap agreement

 

 

 

 

 

1,504

 

 

 

 

 

 

1,504

 

Investment in Shockwave Medical

 

 

79,527

 

 

 

 

 

 

 

 

 

79,527

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

 

 

 

 

 

 

 

23,701

 

 

 

23,701

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

March 31, 2020

 

(in $000's)

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

115,019

 

 

$

 

 

$

 

 

$

115,019

 

Repurchase agreements

 

 

 

 

 

20,000

 

 

 

 

 

 

20,000

 

Short-term U.S. Treasury securities

 

 

 

 

 

42,648

 

 

 

 

 

 

42,648

 

Short-term government-backed securities

 

 

 

 

 

67,995

 

 

 

 

 

 

67,995

 

Short-term corporate debt securities

 

 

 

 

 

107,301

 

 

 

 

 

 

107,301

 

Short-term commercial paper

 

 

 

 

 

32,831

 

 

 

 

 

 

32,831

 

Long-term government-backed securities

 

 

 

 

 

91,064

 

 

 

 

 

 

91,064

 

Long-term corporate debt securities

 

 

 

 

 

116,731

 

 

 

 

 

 

116,731

 

Cross currency swap agreement

 

 

 

 

 

3,786

 

 

 

 

 

 

3,786

 

Investment in Shockwave Medical

 

 

55,704

 

 

 

 

 

 

 

 

 

55,704

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration

 

 

 

 

 

 

 

 

9,000

 

 

 

9,000

 

Change in Fair Value of Contingent Consideration as Determined by Level 3 Inputs

The following table summarizes the change in fair value, as determined by Level 3 inputs, of the contingent consideration for the three months ended June 30, 2020 and 2019:

 

 

 

 

 

For the Three Months Ended June 30,

 

 

 

 

 

 

2020

 

 

 

2019

 

 

 

 

 

(in $000's)

 

Beginning balance

 

$

9,000

 

 

$

9,575

 

Additions

 

 

13,900

 

 

 

 

Payments

 

 

 

 

 

 

Change in fair value

 

 

801

 

 

 

356

 

Ending balance

 

$

23,701

 

 

$

9,931